What Labeling Mandates And Commercial Promotional Restrictions Apply To Medical Aesthetic Devices Undergoing Clinical Investigation? Key Compliance Tips

For a medical aesthetic device under clinical investigation, the central rule is simple: it must be clearly identified as investigational, and it cannot be commercially promoted as safe or effective before regulatory clearance. The device label should state, “CAUTION — Investigational Device. Limited by law to investigational use.” Its labeling must also communicate the intended use, contraindications, warnings, precautions, potential hazards, and applicable safety alerts. Advertising is generally limited to recruiting study participants through IRB-approved, non-coercive materials that do not claim superiority, guaranteed results, or established safety and effectiveness.

An investigational aesthetic device may be used and described only within the controlled clinical-investigation framework. The distinction between study recruitment and commercial promotion is critical: recruitment may be permitted, but marketing the device as an available or proven treatment is not.

What the Device Label Must Communicate

The Required Investigational-Use Statement

The physical device must visibly bear the statement:

CAUTION — Investigational Device. Limited by law to investigational use.

This identifies the equipment’s regulatory status and helps prevent investigators, staff, patients, and other recipients from treating it as a commercially cleared product.

Intended Use and Clinical Scope

Labeling should clearly define the device’s intended use and the clinical indications being investigated. The device must not be presented as having broader indications than those supported by the approved investigation or applicable regulatory authorization.

For example, using an existing laser or energy-based system for a new dermatological indication may represent a new intended use requiring separate regulatory evaluation.

Warnings, Contraindications, and Hazards

Investigational labeling must disclose clinically relevant contraindications, warnings, precautions, potential adverse effects, and other safety information. This information should be sufficient for qualified study personnel to use the device consistently with the approved investigation and risk controls.

Energy-based devices may also require prominent hazard warnings, such as:

DANGER
LASER RADIATION
DIRECT EXPOSURE TO BEAM

The specific warnings depend on the device’s technology, configuration, risks, and applicable labeling requirements.

Directions for Use

For prescription-use aesthetic equipment, labeling should provide complete directions for use, including clinically significant applications, operating precautions, contraindications, warnings, and potential adverse effects.

The directions must remain consistent with the study protocol and the device’s authorized investigational purpose. They should not imply that untested treatment protocols or expanded clinical applications are already established.

Prescription-Device Language

Where applicable to a prescription device, the immediate label may also need the statement:

CAUTION: Federal law restricts this device to sale by or on the order of a physician
(or authorized licensed practitioner).

This prescription-device statement addresses distribution restrictions. It does not replace the separate investigational-device statement required for a device being studied before commercial clearance.

What Promotional Activity Is Prohibited

No Commercialization Before Clearance

An investigational device cannot be commercially marketed, distributed, or offered as an ordinary treatment before the required regulatory clearance or approval.

This restriction applies even when the equipment is technically functional or when clinicians believe it may provide benefits beyond those established during the investigation.

No Test-Marketing

Test-marketing an investigational aesthetic device is prohibited when the activity functions as commercial promotion or creates the impression that the device is available for routine purchase or treatment.

A clinical study is intended to generate controlled evidence, not to create early market demand.

No Safety or Effectiveness Claims

Promotional materials must not claim or imply that the investigational device is:

Safe for general clinical use
Effective for a particular treatment outcome
Superior to competing devices
Clinically proven
Guaranteed to produce a specific result

These restrictions apply to statements made in advertisements, websites, brochures, presentations, social media, sales materials, and other public communications.

No Expansion of the Device’s Intended Use

A clinic or manufacturer should not promote uses that fall outside the approved investigation or established regulatory indication.

A new treatment menu, upgraded feature, or novel protocol may require additional regulatory review, particularly where it changes the device’s intended use, manufacturing process, or risk profile.

What Recruitment Advertising May Permit

Recruitment Is Different From Promotion

Advertising may be permitted when its purpose is to solicit study participants, rather than to sell the device or promote it as a treatment.

Recruitment materials should describe relevant study information, such as the condition being studied, basic eligibility requirements, study location, and how to contact the research team.

IRB Review and Approval

Recruitment advertisements should be reviewed and approved by the applicable Institutional Review Board before use.

The materials should be consistent with the approved protocol and consent process. Unapproved revisions, new claims, or promotional embellishments can create compliance problems even when the original advertisement was acceptable.

Recruitment Must Be Non-Coercive

Recruitment materials must not pressure people to participate or promise outcomes that the investigation cannot support.

Claims of guaranteed improvement, exaggerated benefits, unsupported urgency, or language suggesting that participation is the only way to obtain an effective treatment can make the recruitment process coercive or misleading.

Recruitment Materials Must Avoid Superiority Claims

A recruitment advertisement may identify the investigational device and explain that it is being studied, but it should not claim that the device is better than existing treatments or that participants are guaranteed a particular result.

The device should be described as investigational, with its safety and effectiveness still under evaluation.

Understanding the Trade-offs

Clear Warnings Can Limit Marketing Flexibility

The required investigational language may make promotional communication less attractive from a commercial perspective. That is intentional: patients and practitioners must understand that the device has not yet received the relevant commercial clearance.

Clinical Enthusiasm Does Not Establish Clearance

Positive early findings, clinician experience, or favorable patient feedback do not authorize commercial claims. Regulatory status depends on the applicable submission, review, and authorization process, not on informal evidence or market interest.

Existing Hardware Does Not Automatically Permit New Uses

A device that is already cleared for one indication may still require regulatory review before it is marketed for a new clinical use.

This is particularly important for aesthetic systems whose software, treatment parameters, accessories, manufacturing controls, or protocols are modified.

Delayed Review Does Not Create a Marketing Exception

Regulatory evaluation may take months or years, but the delay does not authorize premature promotion. Until the relevant clearance or approval is granted, the device must remain within the boundaries of the authorized investigation.

Labeling Must Match Actual Study Controls

Warnings and directions that do not reflect the protocol, device configuration, or known risks can undermine participant safety and regulatory compliance.

Labeling should therefore be reviewed alongside the clinical protocol, investigator training, consent materials, and device-change controls.

Making the Right Choice for Your Goal

The safest approach is to separate every communication into either study recruitment or commercial promotion, then apply the stricter requirements to the latter.

If your primary focus is conducting the clinical investigation: Mark the device with the required investigational-use statement and maintain labeling that accurately describes its intended use, contraindications, warnings, precautions, hazards, and directions for use.
If your primary focus is recruiting study participants: Use only IRB-approved, non-coercive materials that identify the study without promising outcomes or making safety, effectiveness, or superiority claims.
If your primary focus is promoting the device commercially: Wait for the applicable regulatory clearance or approval before marketing it as an available treatment or making claims about its safety or effectiveness.
If your primary focus is expanding an existing device’s treatment menu: Confirm that the new indication, protocol, hardware, software, or manufacturing change is covered by the applicable regulatory authorization before promoting it.

Treating the device as investigational in every label and public communication preserves the integrity of the study and protects both participants and the organization conducting it.

Summary Table:

Aspect	Requirement
Label Statement	Must bear 'CAUTION — Investigational Device. Limited by law to investigational use.'
Additional Labeling	Include intended use, contraindications, warnings, precautions, hazards, and directions for use.
Prohibited Promotions	No commercialization, safety/effectiveness claims, superiority claims, or expanded intended use.
Allowed Recruitment	IRB-approved, non-coercive materials that describe the study without promising outcomes.
Prescription Devices	May need 'CAUTION: Federal law restricts this device to sale by or on the order of a physician.'

Ensure your medical aesthetic devices comply with all labeling and promotional regulations. Contact BELIS today for expert guidance and high-quality, certified aesthetic equipment. Our professional-grade systems—including laser, IPL, HIFU, and more—are designed for clinics and premium salons, supported by comprehensive compliance assistance. Get in touch with us to learn how we can elevate your practice with reliable, advanced technology.